F.M. Mottaghy

Lütje, S., Schaefer, L., Altunay, B., Hertel, F., Morgenroth, A., & Mottaghy, F. M. (2025). Advancements in non-invasive visualization of the immune checkpoint TIGIT: a systematic review. European Journal of Nuclear Medicine and Molecular Imaging, 53(1), 59-70. https://doi.org/10.1007/s00259-025-07439-0

Girbig, R. M., Rix, A., Baier, J., Tix, L., Hartmann, A. M., Liu, W., Paschenda, P., Florea, A., Sadeghzadeh, M., Becker, K., Palme, R., Mottaghy, F. M., Tolba, R., & Kiessling, F. (2025). [¹⁸F]Fluspidine PET/CT imaging to assess postoperative pain-associated σ1 receptor expression in female rats under analgesia. European Radiology Experimental, 9(1), Article 108. https://doi.org/10.1186/s41747-025-00646-2

Altunay, B., Obradovic, L., Florea, A., Vogg, A. T. J., Schafer, L., Morgenroth, A., Meszaros, L. K., Hertel, F., Juweid, M. E., & Mottaghy, F. M. (2025). Theranostic application of radiolabeled HER2-targeting single-domain antibodies (RAD202) in preclinical setting. Scientific Reports, 15(1), Article 38468. https://doi.org/10.1038/s41598-025-25679-w

Altunay, B., Schäfer, L., Morgenroth, A., Peña, Q., Lammers, T., Saar, M., Mottaghy, F. M., & Lütje, S. (2025). Combining PSMA-Targeted Radiopharmaceutical Therapy with Immunotherapy. Journal of Nuclear Medicine, 66(10), 1522-1527. https://doi.org/10.2967/jnumed.125.270317

Ocal, O., Zech, C. J., Bali, M. A., Pasquier, D., Mottaghy, F., Einspieler, I., Kartalis, N., Bargellini, I., Iezzi, R., Denecke, T., Kunz, W. G., Gebauer, B., Wege, H., Cannella, R., Oprea-Lager, D. E., Vogel, A., Sangro, B., & Seidensticker, M. (2025). Correction: Imaging in staging, treatment planning, and monitoring of hepatocellular carcinoma for local and locoregional therapies: consensus recommendations from EORTC and ESGAR (May 23, 10.1007/s00330-025-11699-7, 2025). European Radiology. https://doi.org/10.1007/s00330-025-12045-7

Rosen, J., Werner, J.-M., Ceccon, G. S., Rosen, E. K., Wollring, M. M., Stetter, I., Lohmann, P., Mottaghy, F. M., Marner, L., Law, I., Fink, G. R., Langen, K.-J., & Galldiks, N. (2025). Diagnosis of treatment-related changes in children and adolescents with brain and spinal tumors: a cost-effectiveness analysis using MRI and [18 F]FET PET. European Journal of Nuclear Medicine and Molecular Imaging, 52(12), 4616-4626. https://doi.org/10.1007/s00259-025-07377-x

Kuppers, F., Kassem, M., Yun, S. D., Stoffels, G., Filss, C., Galldiks, N., Mottaghy, F. M., Kooi, M. E., Langen, K.-J., Lohmann, P., & Shah, N. J. (2025). Brain Tumor Characterization Using Multiple MR Parameters From Multi-Contrast EPI With Keyhole (GE-SE EPIK) Including Oxygen Extraction Fraction: A Comparison to O-(2-[18F]Fluoroethyl)-L-Tyrosine (FET) Positron Emission Tomography. Journal of Magnetic Resonance Imaging, 62(3), 721-736. https://doi.org/10.1002/jmri.29795

Langen, K.-J., Galldiks, N., Lohmann, P., & Mottaghy, F. M. (2025). Influence of oral protein intake on [<SUP>18</SUP>F]FET uptake in brain tumours. EJNMMI Research, 15(1), Article 109. https://doi.org/10.1186/s13550-025-01304-9

Gavriilidis, P., Koole, M., Mottaghy, F. M., Jansen, F. P., & Wierts, R. (2025). Clinical evaluation of tissue-dependent and spatially-variant positron range correction for Gallium-68 PET imaging. European Journal of Nuclear Medicine and Molecular Imaging. Advance online publication. https://doi.org/10.1007/s00259-025-07456-z

Wang, Y., Barmin, R., Mottaghy, F. M., Kiessling, F., Lammers, T., & Pallares, R. M. (2025). Nanoparticles in nuclear medicine: From diagnostics to therapeutics. Journal of Controlled Release, 383, Article 113815. https://doi.org/10.1016/j.jconrel.2025.113815